A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas (Q44834795)
Jump to navigation
Jump to search
scientific article published on 30 December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas |
scientific article published on 30 December 2003 |
Statements
1 reference
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas (English)
1 reference
Johannes Schetelig
1 reference
Gunilla Enblad
1 reference
Hans Hagberg
1 reference
Martin Erlanson
1 reference
Jeanette Lundin
1 reference
Anja Porwit MacDonald
1 reference
Roland Repp
1 reference
Gernot Seipelt
1 reference
Anders Osterborg
1 reference
30 December 2003
1 reference
Identifiers
1 reference